International Journal of Drug Delivery Technology
Volume 14, Issue 1

Crocin Exerts Neuroprotective Effect in Valproate Exposed Rat Model of Autistic Spectrum Disorder by Ameliorating Behavioural and Biochemical Reversions

Sagarika Majhi1,2*, Sokindra Kumar1

1Faculty of Pharmacy, Swami Vivekanand Subharti University, Meerut, Uttar Pradesh, India.

2I.T.S College of Pharmacy, Ghaziabad, Uttar Pradesh, India. 

Received: 25th July, 2023; Revised: 21st January, 2024; Accepted: 28th February, 2024; Available Online: 25th March, 2024

ABSTRACT

Autistic spectrum disorder (ASD) is associated with oxidative stress and neuron damage triggered by valproic acid (VPA) in a post-natal rat model of ASD. It was hypothesized that crocin (CRO), may have beneficial effects in ASD due to its antioxidant activities. The study investigated the neuro-behavioural and biochemical modifications of crocin in VPA-induced ASD. Wistar albino rat pups aged 13 days were divided into five groups (06 each). 400 mg/kg VPA subcutaneously on PND 14 successfully induced autism. From PND 14 to 40, crocin was dispensed daily. Different neuro-behavioral markers were examined while the groups were receiving therapy. Animals were sacrificed at the completion of the research for biochemical calculations. Crocin treatment significantly improved behavioral activity and oxidative changes compared to animals treated with the VPA-exposed group. The effects were more pronounced at higher dose of crocin, providing evidence of reversing the valproic acid-induced autistic deficits. Crocin could be a viable option for ASD treatment due to its potential neuronal cytoprotective effects, likely attributed to its antioxidant properties.

Keywords: Autism spectrum disorder, Oxidative stress, Neuroprotective activity, Crocin, Valproic acid, Postnatal day. International Journal of Drug Delivery Technology (2024); DOI: 10.25258/ijddt.14.1.03

How to cite this article: Majhi S, Kumar S. Crocin Exerts Neuroprotective Effect in Valproate Exposed Rat Model of Autistic Spectrum Disorder by Ameliorating Behavioural and Biochemical Reversions. International Journal of Drug Delivery Technology. 2024;14(1):14-22.

REFERENCES

  1. Rossignol DA, Bradstreet JJ. Evidence of Mitochondrial Dysfunction in Autism and Implications for Treatment. Am J Biochem Biotechnol [Internet]. 2008 Jun 30 [cited 2023 Apr 25];4(2):208–17. Available from: https://thescipub.com/abstract/ ajbbsp.2008.208.217
  2. Alshammary RAA, Jouda J, Al-Salihy Some Immunological and Physiological Parameters Levels in Iraq Children with Autism Spectrum Disorders. International Journal of Drug Delivery Technology. 2023 Sep 25;13(03):955–60.
  3. Autism Spectrum Disorder - National Institute of Mental Health (NIMH) [Internet]. [cited 2024 Jan 10]. Available from: https:// nimh.nih.gov/health/topics/autism-spectrum-disorders-asd
  4. Volkmar FR, Pauls D. Autism. Lancet [Internet]. 2003 Oct 4 [cited 2023 Apr 25];362(9390):1133–41. Available from: https:// pubmed.ncbi.nlm.nih.gov/14550703/
  5. Gerlai R, Gerlai J. Autism: A target of pharmacotherapies? Drug Discov Today [Internet]. 2004 Apr 15 [cited 2023 Apr 25];9(8):366–74. Available from: https://pubmed.ncbi.nlm.nih.gov/15081964/
  6. Llaneza DC, DeLuke S V., Batista M, Crawley JN, Christodulu K V., Frye CA. Communication, interventions, and scientific advances in autism: a commentary. Physiol Behav [Internet]. 2010 Jun [cited 2023 Apr 25];100(3):268–76. Available from: https://pubmed.ncbi.nlm.nih.gov/20093134/
  7. Ardinger HH, Atkin JF, Blackston RD, Elsas LJ, Clarren SK, Livingstone S, et Verification of the fetal valproate syndrome phenotype. Am J Med Genet [Internet]. 1988 [cited 2023 Apr 25];29(1):171–85. Available from: https://pubmed.ncbi.nlm.nih. gov/3125743/
  8. Data & Statistics on Autism Spectrum Disorder | CDC [Internet]. [cited 2024 Jan 10]. Available from: https://www.cdc.gov/ncbddd/ autism/data.html
  9. Moore SJ, Turnpenny P, Quinn A, Glover S, Lloyd DJ, Montgomery T, et al. A clinical study of 57 children with fetal anticonvulsant syndromes. J Med Genet [Internet]. 2000 [cited 2024 Jan 10];37(7):489–97. Available from: https://pubmed.ncbi. nlm.nih.gov/10882750/
  10. Christensen J, Grnøborg TK, Srøensen MJ, Schendel D, Parner ET, Pedersen LH, et Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA [Internet]. 2013 Apr 24 [cited 2024 Jan 10];309(16):1696–703.Available from: https://pubmed.ncbi.nlm.nih.gov/23613074/
  11. Bromley RL, Mawer GE, Briggs M, Cheyne C, Clayton-Smith J, García-Fiñana M, et al. The prevalence of neurodevelopmental disorders in children prenatally exposed to antiepileptic drugs. J Neurol Neurosurg Psychiatry [Internet]. 2013 [cited 2024 Jan 10];84(6):637–43. Available from: https://pubmed.ncbi.nlm.nih. gov/23370617/
  12. Williams G, King J, Cunningham M, Stephan M, Kerr B, Hersh JH. Fetal valproate syndrome and autism: additional evidence of an association. Dev Med Child Neurol [Internet]. 2001 Mar 1 [cited 2023 Apr 25];43(3):202–6. Available from: https:// wiley.com/doi/full/10.1111/j.1469-8749.2001. tb00188.x
  13. Wagner GC, Reuhl KR, Cheh M, McRae P, Halladay A new neurobehavioral model of autism in mice: pre- and post-natal exposure to sodium valproate. J Autism Dev Disord [Internet]. 2006 Aug [cited 2022 Jun 28];36(6):779–93. Available from: https://pubmed.ncbi.nlm.nih.gov/16609825/
  14. Yochum CL, Dowling P, Reuhl KR, Wagner GC, Ming VPA- induced apoptosis and behavioral deficits in neonatal mice. Brain Res [Internet]. 2008 Apr 8 [cited 2023 Apr 25];1203:126–32. Available from: https://pubmed.ncbi.nlm.nih.gov/18316065/
  15. Majhi S, Kumar S, Singh L. A Review on Autism Spectrum Disorder: Pathogenesis, Biomarkers, Pharmacological and Non- Pharmacological CNS Neurol Disord Drug Targets [Internet]. 2023 Apr 30 [cited 2023 Jul 21];22(5):659–77. Available from: https://pubmed.ncbi.nlm.nih.gov/36915952/
  16. Skladnev N V., Johnstone DM. Neuroprotective properties of dietary saffron: more than just a chemical scavenger? Neural Regen Res [Internet]. 2017 Feb 1 [cited 2023 Jan 5];12(2):210–1. Available from: https://pubmed.ncbi.nlm.nih.gov/28400798/
  17. Elsherbiny NM, Salama MF, Said E, El-Sherbiny M, Al-Gayyar MMH. Crocin protects against doxorubicin-induced myocardial toxicity in rats through down-regulation of inflammatory and apoptic pathways. Chem Biol Interact [Internet]. 2016 Mar 5 [cited 2023 Jan 5];247:39–48. Available from: https://pubmed. nlm.nih.gov/26807765/
  18. Hosseinzadeh H, Sadeghnia HR, Ghaeni FA, Motamedshariaty VS, Mohajeri SA. Effects of saffron (Crocus sativus L.) and itsactive constituent, crocin, on recognition and spatial memory after chronic cerebral hypoperfusion in rats. Phytother Res [Internet]. 2012 Mar [cited 2023 Jan 5];26(3):381–6. Available from: https://pubmed.ncbi.nlm.nih.gov/21774008/
  19. Vahdati Hassani F, Naseri V, Razavi BM, Mehri S, Abnous K, Hosseinzadeh Antidepressant effects of crocin and its effects on transcript and protein levels of CREB, BDNF, and VGF in rat hippocampus. Daru [Internet]. 2014 Jan 8 [cited 2023 Jan 5];22(1). Available from: https://pubmed.ncbi.nlm.nih.gov/24401376/
  20. Xiao Q, Shu R, Wu C, Tong Y, Xiong Z, Zhou J, et Crocin-I alleviates the depression-like behaviors probably via modulating “microbiota-gut-brain” axis in mice exposed to chronic restraint stress. J Affect Disord [Internet]. 2020 Nov 1 [cited 2023 Jan 5];276:476–86. Available from: https://pubmed.ncbi.nlm.nih. gov/32871679/
  21. Thomas A, Burant A, Bui N, Graham D, Yuva-Paylor LA, PaylorMarble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety. Psychopharmacology (Berl) [Internet]. 2009 Jun [cited 2023 Jan 5];204(2):361–73. Available from: https://pubmed.ncbi.nlm.nih.gov/19189082/
  22. Banji D, Banji OJF, Abbagoni S, Hayath MS, Kambam S, Chiluka VL. Amelioration of behavioral aberrations and oxidative markers by green tea extract in valproate induced autism in animals. Brain Res [Internet]. 2011 Sep 2 [cited 2023 Jan 5];1410:141–51. Available from: https://pubmed.ncbi.nlm. gov/21820650/
  23. Bakshi V, Sunand K, Begum N, Kakalij RM, Tekula MR. Neuroprotective Effect of Resveratrol on Valproic Acid induced Oxidative Stress Autism in Swiss Albino Mice. International Journal of Pharmaceutical Sciences and Drug Research [Internet]. 2018 May 1 [cited 2023 Jan 5];10(03):103–10. Available from: https://www.ijpsdr.com/index.php/ijpsdr/article/view/615
  24. Schneider T, Przewłocki R. Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism. Neuropsychopharmacology [Internet]. 2005 Jan [cited 2023 Jan 5];30(1):80–9. Available from: https://pubmed.ncbi.nlm.nih. gov/15238991/
  25. Barendse EM, Hendriks MP, Jansen JF, Backes WH, Hofman PA, Thoonen G, et Working memory deficits in high-functioning adolescents with autism spectrum disorders: neuropsychological and neuroimaging correlates. J Neurodev Disord [Internet]. 2013 Dec [cited 2023 Jan 5];5(1). Available from: https://pubmed.ncbi. nlm.nih.gov/23731472/
  26. Morris Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods [Internet]. 1984 [cited 2023 Jan 5];11(1):47–60. Available from: https://pubmed. ncbi.nlm.nih.gov/6471907/
  27. Restall G, Magill-Evans J. Play and preschool children with autism. Am J Occup Ther [Internet]. 1994 [cited 2023 Jan 5];48(2):113–20. Available from: https://pubmed.ncbi.nlm.nih. gov/8017504/
  28. Byrge L, Dubois J, Tyszka JM, Adolphs R, Kennedy DP. Idiosyncratic brain activation patterns are associated with poor social comprehension in J Neurosci [Internet]. 2015 Apr 8 [cited 2023 Jan 5];35(14):5837–50. Available from: https:// pubmed.ncbi.nlm.nih.gov/25855192/
  29. Kumar H, Sharma BM, Sharma B. Benefits of agomelatine in behavioral, neurochemical and blood brain barrier alterations in prenatal valproic acid induced autism spectrum disorder. Neurochem Int [Internet]. 2015 Dec 1 [cited 2023 Jan 5];91:34–45. Available from: https://pubmed.ncbi.nlm.nih.gov/26498253/
  30. Singh P, Gupta S, Sharma Melatonin receptor and KATPchannel modulation in experimental vascular dementia. Physiol Behav [Internet]. 2015 Apr 1 [cited 2023 Jan 5];142:66–78. Available from: https://pubmed.ncbi.nlm.nih.gov/25659733/
  31. Georgiadou G, Tarantilis PA, Pitsikas N. Effects of the active constituents of Crocus Sativus L., crocins, in an animal model of obsessive-compulsive Neurosci Lett [Internet]. 2012 Oct 18 [cited 2023 May 2];528(1):27–30. Available from: https:// pubmed.ncbi.nlm.nih.gov/22985509/
  32. Lopresti AL, Drummond Saffron (Crocus sativus) for depression: a systematic review of clinical studies and examination of underlying antidepressant mechanisms of action. Hum Psychopharmacol [Internet]. 2014 Nov 1 [cited 2023 May 2];29(6):517–27. Available from: https://pubmed.ncbi.nlm.nih. gov/25384672/
  33. Taheri-Amlashi M, Hassanpour S, Vazir Effects of the prenatal exposure to crocin in the expression of withdrawal syndrome on reflexive motor behaviors in mice offspring’s. Neurosci Lett [Internet]. 2022 Jan 1 [cited 2023 May 2];766. Available from: https://pubmed.ncbi.nlm.nih.gov/34788677/
  34. Altinoz E, Oner Z, Elbe H, Vardi N. Neuro-protective effects of crocin on brain and cerebellum tissues in diabetic rats. African Journal of Traditional, Complementary and Alternative Medicines [Internet]. 2015 Apr 9 [cited 2023 May 2];11(6):33–9. Available from: https://www.ajol.info/index.php/ajtcam/article/ view/115422
  35. Tashakori A, Hassanpour S, Vazir B. Protective effect of crocin on cuprizone-induced model of multiple sclerosis in mice. Naunyn Schmiedebergs Arch Pharmacol [Internet]. 2023 [cited 2023 May 2]; Available from: https://pubmed.ncbi.nlm.nih.gov/36805765/
  36. Markram K, Rinaldi T, Mendola D La, Sandi C, Markram H. Abnormal fear conditioning and amygdala processing in an animal model of autism. Neuropsychopharmacology [Internet]. 2008 Mar [cited 2023 Apr 21];33(4):901–12. Available from: https://pubmed.ncbi.nlm.nih.gov/17507914/
  37. Yuan Y, Shan X, Men W, Zhai H, Qiao X, Geng L, et al. The effect of crocin on memory, hippocampal acetylcholine level, and apoptosis in a rat model of cerebral ischemia. Biomed Pharmacother [Internet]. 2020 Oct 1 [cited 2023 May 2];130. Available from: https://pubmed.ncbi.nlm.nih.gov/32738637/
  38. Fisher BE, Boyd L, Winstein Contralateral cerebellar damage impairs imperative planning but not updating of aimed arm movements in humans. Exp Brain Res [Internet]. 2006 Oct [cited 2023 May 3];174(3):453–66. Available from: https://pubmed.ncbi. nlm.nih.gov/16741716/
  39. Fine EJ, Ionita CC, Lohr L. The history of the development of the cerebellar examination. Semin Neurol [Internet]. 2002 Dec [cited 2023 May 3];22(4):375–84. Available from: https://pubmed. nlm.nih.gov/12539058/
  40. Hosseinzadeh H, Noraei NB. Anxiolytic and hypnotic effect of Crocus sativus aqueous extract and its constituents, crocin and safranal, in Phytother Res [Internet]. 2009 Jun [cited 2023 May 3];23(6):768–74. Available from: https://pubmed.ncbi.nlm. nih.gov/19142981/
  41. Georgiadou G, Grivas V, Tarantilis PA, Pitsikas Crocins, the active constituents of Crocus Sativus L., counteracted ketamine- induced behavioural deficits in rats. Psychopharmacology (Berl) [Internet]. 2014 Feb [cited 2023 May 3];231(4):717–26. Available from: https://pubmed.ncbi.nlm.nih.gov/24096536/
  42. Anand A, Shekhar Brain imaging studies in mood and anxiety disorders: special emphasis on the amygdala. Ann N Y Acad Sci [Internet]. 2003 [cited 2023 Apr 21];985:370–88. Available from: https://pubmed.ncbi.nlm.nih.gov/12724172/
  43. Pitsikas N, Zisopoulou S, Tarantilis PA, Kanakis CD, Polissiou MG, Sakellaridis Effects of the active constituents of Crocus sativus L., crocins on recognition and spatial rats’ memory. Behavioural brain research [Internet]. 2007 Nov 2 [cited 2023 May 3];183(2):141–6. Available from: https://pubmed.ncbi.nlm. nih.gov/17628713/
  44. Pitsikas N, Boultadakis A, Georgiadou G, Tarantilis PA, Sakellaridis N. Effects of the active constituents of Crocus sativus , crocins, in an animal model of anxiety. Phytomedicine [Internet]. 2008 Dec [cited 2023 May 3];15(12):1135–9. Available from: https://pubmed.ncbi.nlm.nih.gov/18693098/
  45. Natori T, Kodaira F, Hirasawa T, Gao YY, Nagai Augmentation of polysialic acid by valproic acid in early post-natal mouse hippocampus and primary cultured hippocampal neurons. J Biosci Bioeng [Internet]. 2008 Feb [cited 2023 May 3];105(2):164–Available from: https://pubmed.ncbi.nlm.nih.gov/18343346/
  46. Wang C, Luan Z, Yang Y, Wang Z, Cui Y, Gu G. Valproic acid induces apoptosis in differentiating hippocampal neurons by the release of tumor necrosis factor-α from activated astrocytes. Neurosci Lett [Internet]. 2011 Jun 22 [cited 2023 May 3];497(2):122–7. Available from: https://pubmed.ncbi.nlm. gov/21543053/
  47. Berger F, Hensel A, Nieber Saffron extract and trans-crocetin inhibit glutamatergic synaptic transmission in rat cortical brain slices. Neuroscience [Internet]. 2011 Apr 28 [cited 2023 May 3];180:238–47. Available from: https://pubmed.ncbi.nlm.nih. gov/21352900/
  48. Chauhan A, Chauhan Oxidative stress in autism. Pathophysiology [Internet]. 2006 Aug [cited 2023 Apr 21];13(3):171–81. Available from: https://pubmed.ncbi.nlm.nih. gov/16766163/
  49. Sandhya T, Sowjanya J, Veeresh B. Bacopa monniera (L.) Wettst ameliorates behavioral alterations and oxidative markers in sodium valproate induced autism in rats. Neurochem Res [Internet]. 2012 May [cited 2023 Mar 28];37(5):1121–31. Available from: https://pubmed.ncbi.nlm.nih.gov/22322665/
  50. Kermanshahi S, Ghanavati G, Abbasi-Mesrabadi M, Gholami M, Ulloa L, Motaghinejad M, et Novel Neuroprotective Potential of Crocin in Neurodegenerative Disorders: An Illustrated Mechanistic Review. Neurochem Res [Internet]. 2020 Nov 1 [cited 2023 May 4];45(11):2573–85. Available from: https:// pubmed.ncbi.nlm.nih.gov/32940861/
  51. Rajaei Z, Hadjzadeh MAR, Nemati H, Hosseini M, Ahmadi M, Shafiee Antihyperglycemic and antioxidant activity of crocin in streptozotocin-induced diabetic rats. J Med Food [Internet]. 2013 Mar 1 [cited 2023 May 4];16(3):206–10. Available from: https://pubmed.ncbi.nlm.nih.gov/23437790/
  52. Chen Y, Zhang H, Tian X, Zhao C, Cai L, Liu Y, et Antioxidant potential of crocins and ethanol extracts of Gardenia jasminoides and Crocus sativus L.: A relationship investigation between antioxidant activity and crocin contents. Food Chem. 2008 Aug 1;109(3):484–92.
  53. Knott C, Stern G, Wilkin GP. Inflammatory regulators in Parkinson’s disease: iNOS, lipocortin-1, and cyclooxygenases-1 and -2. Mol Cell Neurosci [Internet]. 2000 [cited 2023 May 4];16(6):724–39. Available from: https://pubmed.ncbi.nlm.nih. gov/11124893/
  54. Nam KN, Park YM, Jung HJ, Lee JY, Min BD, Park SU, et al. Anti-inflammatory effects of crocin and crocetin in rat brain microglial cells. Eur J Pharmacol [Internet]. 2010 Dec 1 [cited 2023 May 4];648(1–3):110–6. Available from: https://pubmed. nlm.nih.gov/20854811/